2 stories mentioning SHE:301263Updated 48d ago
Every FINWIRES story that references SHE:301263, newest first.
Guangdong Taienkang Pharmaceutical (SHE:301263) directors approved the change in the company's registered capital and total share capital.The registered capital rose to 510.6 million yuan from 425.5 million yuan, while the number of shares increased to 510.6 million from 425.5 million, according to a Thursday filing with the Shenzhen bourse.
Guangdong Taienkang Pharmaceutical (SHE:301263) said its Phase IIa clinical trial for CKBA Cream in treating papulopustular rosacea has completed enrollment of all 15 subjects, with positive preliminary data prompting early initiation of Phase IIb.The trial showed significant inflammatory lesion reduction after eight weeks and no serious adverse reactions, according to a Monday filing with the Shenzhen bourse.Shares of the drugmaker rose 1% in recent trade.
